Culwell Kelly 4
4 · Evofem Biosciences, Inc. · Filed Jun 12, 2019
Insider Transaction Report
Form 4
Culwell Kelly
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2019-06-10$6.36/sh−5,187$32,989→ 55,776 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on June 10, 2019. No shares were sold in connection with this transaction.